Unfortunately, due to the relatively small number of female patients with PRL+ GBM, we could not perform a statistical analysis with enough power to conclusively compare the survival of female patients harbouring PRL+/PRLRHIGH and PRL+/PRLRLOW GBM. This evidence concerns the gene PRL and glioblastoma.